Clinical effects of methylphenidate and thioridazine in intellectually subaverage children

Area of Science:

• Child and Adolescent Psychiatry
• Neurodevelopmental Disorders
• Pharmacology

Background:

• Attention deficit disorder and conduct disorder are common psychiatric conditions in children.
• Subaverage IQs can complicate treatment and influence drug response.
• Understanding medication efficacy in relation to cognitive function is crucial.

Purpose of the Study:

• To evaluate the efficacy of methylphenidate and thioridazine in children with attention deficit disorder and/or conduct disorder.
• To investigate the influence of cognitive factors, such as IQ and attention, on stimulant drug response.
• To compare the effects of methylphenidate and thioridazine on behavioral problems.

Main Methods:

• A double-blind, placebo-controlled study involving 30 children with subaverage IQs.
• Each child received methylphenidate, thioridazine, and placebo for three-week periods.
• Subjects were analyzed based on an attentional model, including breadth of attention, mental age, and IQ level.

Main Results:

• Methylphenidate demonstrated a significant reduction in teacher-rated problem behaviors.
• Parent ratings did not show significant group-wide behavioral effects.
• Higher-functioning children responded favorably to methylphenidate, while lower-functioning children showed adverse or indifferent responses.
• Thioridazine showed less clinical response compared to methylphenidate, with improvements mainly in conduct and hyperactivity.

Conclusions:

• Methylphenidate is effective in reducing behavioral problems in children with attention deficit disorder and conduct disorder, particularly in those with higher cognitive functioning.
• Mental age and IQ are significant determinants of positive response to methylphenidate.
• Children with lower IQs and mental ages are less likely to benefit from methylphenidate treatment.